References
- Arokiyaraj S, Stalin A, Kannan BS, Shin H. 2020. Geranii Herba as a potential inhibitor of SARS-CoV-2 main 3CL(pro), spike RBD, and regulation of unfolded protein response: an in silico approach. Antibiotics. 9(12):863.
- Cao B, Wang Y, Wen D, Liu W, Wang JL, Fan G, Ruan L, Song B, Cai Y, Wei M, et al. 2020. A trial of Lopinavir-Ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 382(19):1787–1799.
- Fatma B, Kumar R, Singh VA, Nehul S, Sharma R, Kesari P, Kuhn RJ, Tomar S. 2020. Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection. Antiviral Res. 179:104808.
- Fu LF, Ye F, Feng Y, Yu F, Wang QS, Wu Y, Zhao C, Sun H, Huang BY, Niu PH, et al. 2020. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 11(1):4417.
- Hiremath S, Kumar HDV, Nandan M, Mantesh M, Shankarappa KS, Venkataravanappa V, Basha CRJ, Reddy CNL. 2021. In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2. 3 Biotech. 11(2):44.
- Wang P, Qiao Q, Li J, Wang W, Yao LP, Fu YJ. 2016. Inhibitory effects of geraniin on LPS-induced inflammation via regulating NF-κB and Nrf2 pathways in RAW 264.7 cells . Chem Biol Interact. 253:134–142.
- Zhang LL, Lin DZ, Sun XYY, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R. 2020. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 368(6489):409–412.